Literature DB >> 22233688

Re: "cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study.

Luca Ansaloni, Pierandrea De Iaco, Luigi Frigerio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22233688     DOI： 10.1016/j.ygyno.2012.01.001

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  4 in total

Review 1.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03

Review 2.  Narrative review of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced ovarian cancer: a critical reappraisal of the current evidence.

Authors:  John Spiliotis; Anastasia Prodromidou
Journal:  J Gastrointest Oncol       Date:  2021-04

3.  Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study.

Authors:  Marco Ceresoli; Apollonia Verrengia; Giulia Montori; Luisa Busci; Federico Coccolini; Luca Ansaloni; Luigi Frigerio
Journal:  J Gynecol Oncol       Date:  2018-03-12       Impact factor: 4.401

4.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience.

Authors:  Giulia Montori; Federico Coccolini; Paola Fugazzola; Marco Ceresoli; Matteo Tomasoni; Carolina Rubicondo; Stefano Raimondo; Domenico Pinelli; Michele Colledan; Luigi Frigerio; Luca Ansaloni
Journal:  J Gastrointest Oncol       Date:  2018-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.